Related Experiment Video
Updated: Jun 14, 2026

08:07
The Microfluidic Probe: Operation and Use for Localized Surface Processing
Published on: June 4, 2009
9.4K
Erasable FAP Targeted Spray-On Probe for Fluorescence-Guided Surgery
Zachary Rabinowitz1, Riley J Deutsch-Williams1, Ralph Weissleder1,2
1Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|March 24, 2026
Summary
Researchers developed a novel erasable spray-on probe (ESOP) for fluorescence-guided surgery. This innovative probe enhances real-time cancer detection and allows for iterative visualization by erasing signals with UV light.
Area of Science:
- Biomedical Engineering
- Surgical Oncology
- Molecular Imaging
Background:
- Fluorescence-guided surgery (FGS) enhances real-time cancer detection and therapeutic decisions.
- Current fluorescent affinity probes (FAPs) include systemically injected and spray-on types.
- A key challenge in FGS is developing 'turn-off' probes to reduce background noise during iterative procedures.
Purpose of the Study:
- To develop and characterize the first FAP-targeted erasable spray-on probe (ESOP).
- To evaluate the probe's efficacy in sensitive tumor-specific margin visualization.
- To demonstrate the probe's capacity for iterative applications via UV-induced signal erasure.
Main Methods:
- Development of a novel ESOP comprising a rhodamine dye, a photo-responsive triazene linker, and a FAP affinity ligand.
- Application of the ESOP as a spray onto tissue for real-time imaging.
- Erasure of fluorescent signals using a 2-minute UV light pulse for iterative staining.
Main Results:
- The ESOP enabled highly sensitive, tumor-specific margin visualization within minutes of spray application.
- Fluorescent signals were completely erased by UV light, allowing for repeated staining.
- Consistently high tumor-to-background ratios (TBRs) were achieved in iterative applications.
Conclusions:
- FAP-targeted ESOPs are feasible for both cancer and host tissue targeting.
- This technology has the potential to transform next-generation cancer surgeries.
- The development of ESOPs promises to significantly improve patient care through enhanced surgical precision.

